Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease

Fig. 2

CSF SNAP-25 by diagnosis and amyloid pathology. The subjects included in the study were classified as Aβ+ or Aβ. CSF SNAP-25 in different combinations of clinical diagnosis and Aβ pathology. Differences between groups were tested by multiple-variable linear regression, adjusted for age and sex. *p < 0.05, **p < 0.01, ***p < 0.0001. AD Alzheimer’s disease, CN cognitively normal, pMCI progressive mild cognitive impairment, sMCI stable mild cognitive impairment, SNAP-25 synaptosomal-associated protein 25

Back to article page